1. Home
  2. OLMA vs HIO Comparison

OLMA vs HIO Comparison

Compare OLMA & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • HIO
  • Stock Information
  • Founded
  • OLMA 2006
  • HIO 1993
  • Country
  • OLMA United States
  • HIO United States
  • Employees
  • OLMA N/A
  • HIO N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • HIO Finance/Investors Services
  • Sector
  • OLMA Health Care
  • HIO Finance
  • Exchange
  • OLMA Nasdaq
  • HIO Nasdaq
  • Market Cap
  • OLMA 378.9M
  • HIO 374.7M
  • IPO Year
  • OLMA 2020
  • HIO N/A
  • Fundamental
  • Price
  • OLMA $7.75
  • HIO $4.03
  • Analyst Decision
  • OLMA Strong Buy
  • HIO
  • Analyst Count
  • OLMA 5
  • HIO 0
  • Target Price
  • OLMA $24.00
  • HIO N/A
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • HIO 305.3K
  • Earning Date
  • OLMA 11-11-2025
  • HIO 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • HIO 10.33%
  • EPS Growth
  • OLMA N/A
  • HIO N/A
  • EPS
  • OLMA N/A
  • HIO N/A
  • Revenue
  • OLMA N/A
  • HIO N/A
  • Revenue This Year
  • OLMA N/A
  • HIO N/A
  • Revenue Next Year
  • OLMA N/A
  • HIO N/A
  • P/E Ratio
  • OLMA N/A
  • HIO N/A
  • Revenue Growth
  • OLMA N/A
  • HIO N/A
  • 52 Week Low
  • OLMA $2.86
  • HIO $3.52
  • 52 Week High
  • OLMA $13.93
  • HIO $4.03
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 64.67
  • HIO 66.21
  • Support Level
  • OLMA $7.49
  • HIO $3.90
  • Resistance Level
  • OLMA $8.40
  • HIO $3.98
  • Average True Range (ATR)
  • OLMA 0.67
  • HIO 0.02
  • MACD
  • OLMA 0.08
  • HIO 0.01
  • Stochastic Oscillator
  • OLMA 75.63
  • HIO 90.91

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: